PERINDOPRIL Side Effects

7008183-4 | Pancytopenia, Renal Failure Acute, Systemic Lupus Erythematosus
on Sep 04, 2010 Female patient from , 55 years of age, was treated with Perindopril (View Usage). Patient experienced the following unwanted or unexpected effects: pancytopenia, renal failure acute, systemic lupus erythematosus. Perindopril dosage: 4mg-daily-oral. During the same period patient was treated with HYDRALAZINE HCL (25mg-bid) (View Hydralazine Hcl Review and Hydralazine Hcl Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ATENOLOL (View Atenolol Review and Atenolol Label ). Patient was hospitalized.

6768871-1 | Ageusia, Anosmia, Biliary Cirrhosis Primary, Bulbar Palsy, Cheilitis, Dry Eye, Dysphagia, Eye Pruritus, Glossodynia
Patient was taking Perindopril (View Usage). Patient had the following side effects: ageusia, anosmia, biliary cirrhosis primary, bulbar palsy, cheilitis, dry eye, dysphagia, eye pruritus, glossodynia on May 27, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 68 years of age, weighting 189.6 lb, was diagnosed with hypertension, cardiovascular event prophylaxis and. Perindopril dosage: 8 Mg (1 In 1 D). During the same period patient was treated with EZETIMIBE (10 Mg (4 In 1 D), Oral) (View Ezetimibe Review and Ezetimibe Label ), CANDESARTAN CILEXETIL (4 Mg (4 In 1 D), Oral) (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ), THYROXINE (LEVOTHYROXINE + THYROXINE) (View Thyroxine (levothyroxine + Thyroxine) Review and Thyroxine (levothyroxine + Thyroxine) Label ), URSODIOL (View Ursodiol Review and Ursodiol Label ).

6742385-7 | Ageusia, Anosmia, Biliary Cirrhosis Primary, Bulbar Palsy, Cheilitis, Dry Eye, Dysphagia, Eye Pruritus, Glossodynia
Adverse event was reported on May 07, 2010 by a Female patient taking Perindopril (View Usage) (Dosage: 8 Mg (1 In 1 D)) was diagnosed with hypertension, cardiovascular event prophylaxis and. Location: UNITED KINGDOM , 68 years of age, weighting 189.6 lb, After Perindopril was administered, patient had the following side effects: ageusia, anosmia, biliary cirrhosis primary, bulbar palsy, cheilitis, dry eye, dysphagia, eye pruritus, glossodynia. During the same period patient was treated with EZETIMIBE (10 Mg (1 In 1 D), Oral) (View Ezetimibe Review and Ezetimibe Label ), CANDESARTAN CILEXETIL (4 Mg (1 In 1 D),oral) (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), BENDROFLUMETHIAZIDE (BENDROFLUMETHIAZIDE) (View Bendroflumethiazide (bendroflumethiazide) Review and Bendroflumethiazide (bendroflumethiazide) Label ), THYROXINE (LEVOTHYROXINE+ THYROXINE) (View Thyroxine (levothyroxine+ Thyroxine) Review and Thyroxine (levothyroxine+ Thyroxine) Label ).

6733095-0 | Angioedema, Salivary Gland Enlargement, Swollen Tongue
on May 06, 2010 Male patient from UNITED KINGDOM , 64 years of age, was diagnosed with acute myocardial infarction and was treated with Perindopril (View Usage). Patient experienced the following unwanted or unexpected effects: angioedema, salivary gland enlargement, swollen tongue. Perindopril dosage: 4 Mg, Oral. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.


6720115-2 | Ageusia, Anosmia, Bulbar Palsy, Chapped Lips, Dry Eye, Dysphagia, Eye Pruritus, Glossodynia, Lip Swelling
on Apr 22, 2010 Female patient from UNITED KINGDOM , 68 years of age, was treated with Perindopril (View Usage). Patient had the following side effects: ageusia, anosmia, bulbar palsy, chapped lips, dry eye, dysphagia, eye pruritus, glossodynia, lip swelling. Perindopril dosage: 8 Mg. During the same period patient was treated with EZETIMIBE (10 Mg (1 In 1 D)) (View Ezetimibe Review and Ezetimibe Label ), CANDESARTAN CILEXETIL (4 Mg (1 In 1 D), Oral) (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ).

6700593-5 | Ageusia, Anosmia, Bulbar Palsy, Burning Sensation, Dry Eye, Eye Pruritus, Lip Swelling, Stomatitis
Patient was taking Perindopril (View Usage). After Perindopril was administered, patient had the following side effects: ageusia, anosmia, bulbar palsy, burning sensation, dry eye, eye pruritus, lip swelling, stomatitis on Apr 09, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 68 years of age, . Perindopril dosage: 8 Mg. During the same period patient was treated with EZETIMIBE MICRONISED (EZETROL) (10 Mg) (View Ezetimibe Micronised (ezetrol) Review and Ezetimibe Micronised (ezetrol) Label ), CANDESARTAN CILEXETIL (AMIAS) (4 Mg) (View Candesartan Cilexetil (amias) Review and Candesartan Cilexetil (amias) Label ).

6482587-0 | Peripheral Sensory Neuropathy, Walking Disability
Adverse event was reported on Nov 26, 2009 by a Female patient taking Perindopril (View Usage) (Dosage: Unk) was diagnosed with osteoporotic fracture and. Location: UNITED KINGDOM , 75 years of age, Patient experienced the following unwanted or unexpected effects: peripheral sensory neuropathy, walking disability. During the same period patient was treated with PRAVASTATIN (Unk) (View Pravastatin Review and Pravastatin Label ), ACTONEL (Unk) (View Actonel Review and Actonel Label ), CALCICHEW (View Calcichew Review and Calcichew Label ), DOCUSATE (View Docusate Review and Docusate Label ), LEVOTHYROXINE SODIUM (100 Ug, Qd) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6326815-0 | Renal Aneurysm, Renal Artery Occlusion, Renal Failure
on Aug 10, 2009 Male patient from POLAND , 18 years of age, was diagnosed with hypertension and was treated with Perindopril (View Usage). Patient had the following side effects: renal aneurysm, renal artery occlusion, renal failure. Perindopril dosage: Daily Dose: 4 Milligram(s). During the same period patient was treated with NITRENDIPINE (Daily Dose: 20 Milligram(s)) (View Nitrendipine Review and Nitrendipine Label ), LISINOPRIL (Daily Dose: 10 Milligram(s)) (View Lisinopril Review and Lisinopril Label ), PRAZSOIN HCL (Daily Dose: 6 Milligram(s)) (View Prazsoin Hcl Review and Prazsoin Hcl Label ), METOPROLOL (Daily Dose: 200 Milligram(s)) (View Metoprolol Review and Metoprolol Label ). Patient was hospitalized.

6169353-0 | Peripheral Sensory Neuropathy, Walking Disability
on Apr 15, 2009 Female patient from UNITED KINGDOM , 75 years of age, was diagnosed with osteoporotic fracture and was treated with Perindopril (View Usage). After Perindopril was administered, patient had the following side effects: peripheral sensory neuropathy, walking disability. Perindopril dosage: . During the same period patient was treated with ACTONEL (Unk) (View Actonel Review and Actonel Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), CALCICHEW (View Calcichew Review and Calcichew Label ), DOCUSATE (View Docusate Review and Docusate Label ), LEVOTHYROXINE SODIUM (100 Ug, Qd) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

5624213-6 | Haemoptysis, Rhabdomyolysis
Patient was taking Perindopril (View Usage). Patient experienced the following unwanted or unexpected effects: haemoptysis, rhabdomyolysis on Jan 30, 2008 from UNITED KINGDOM Additional patient health information: Male patient , 54 years of age, weighting 187.4 lb, was diagnosed with hypertension and. Perindopril dosage: Daily Dose: 4 Milligram(s). Patient was hospitalized.

5554916-3 | Blood Creatine Phosphokinase Increased, Myositis
Adverse event was reported on Dec 05, 2007 by a Male patient taking Perindopril (View Usage) (Dosage: Daily Dose: 4 Milligram(s)) was diagnosed with ventricular dysfunction and. Location: UNITED KINGDOM , 47 years of age, weighting 158.7 lb, Patient had the following side effects: blood creatine phosphokinase increased, myositis (What is myositis?).

5520556-5 | Blood Bicarbonate Decreased, Blood Creatinine Increased, Blood Lactic Acid Increased, Blood Ph Decreased, Capillary Leak Syndrome, Convulsion, Electromechanical Dissociation, Haematocrit Increased, Haemoglobin Increased
on Nov 09, 2007 Male patient from BELGIUM , 59 years of age, was diagnosed with ill-defined disorder and was treated with Perindopril (View Usage). After Perindopril was administered, patient had the following side effects: blood bicarbonate decreased, blood creatinine increased, blood lactic acid increased, blood ph decreased, capillary leak syndrome, convulsion, electromechanical dissociation, haematocrit increased, haemoglobin increased. Perindopril dosage: Daily Dose: 2 Milligram(s). During the same period patient was treated with SIMVASTATIN (Daily Dose: 40 Milligram(s)) (View Simvastatin Review and Simvastatin Label ), BISOPROLOL FUMARATE (Daily Dose: 5 Milligram(s)) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGEL (View Clopidogel Review and Clopidogel Label ), MOLSIDOMINE (View Molsidomine Review and Molsidomine Label ), EZETIMIBE (View Ezetimibe Review and Ezetimibe Label ).

5520394-3 | Abortion Induced
on Nov 12, 2007 Female patient from FRANCE , 21 years of age, was diagnosed with ill-defined disorder, lupus nephritis and was treated with Perindopril (View Usage). Patient experienced the following unwanted or unexpected effects: abortion induced. Perindopril dosage: . During the same period patient was treated with PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), HYDROXYCHLOROQUINE SULFATE (View Hydroxychloroquine Sulfate Review and Hydroxychloroquine Sulfate Label ), MYCOPHENOLATE MOFETIL (Daily Dose: 2000 Milligram(s)) (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ).

4872675-4 | Colon Cancer, Vomiting, Weight Decreased
Patient was taking Perindopril (View Usage). Patient had the following side effects: colon cancer, vomiting, weight decreased on Nov 10, 2005 from FRANCE Additional patient health information: Male patient , 80 years of age, weighting 127.9 lb, was diagnosed with ill-defined disorder and. Perindopril dosage: Daily Dose: 2 Milligram(s). During the same period patient was treated with PRETERAX (Daily Dose: 1 Dosage Form) (View Preterax Review and Preterax Label ), TAHOR (Daily Dose: 1 Dosage Form) (View Tahor Review and Tahor Label ), DETENSIEL (View Detensiel Review and Detensiel Label ), KARDEGIC (View Kardegic Review and Kardegic Label ). Patient was hospitalized.

4815692-2 | Neuralgia
Adverse event was reported on Dec 10, 2004 by a Male patient taking Perindopril (View Usage) (Dosage: Daily Dose: 4 Milligram(s)) was diagnosed with cardiac failure congestive, ill-defined disorder and. Location: HUNGARY , weighting 174.2 lb, After Perindopril was administered, patient had the following side effects: neuralgia. During the same period patient was treated with GLYCERYL TRINITRATE (View Glyceryl Trinitrate Review and Glyceryl Trinitrate Label ), VINPOCETINE (View Vinpocetine Review and Vinpocetine Label ). Patient was hospitalized.

4814554-4 | Bile Duct Stone, Cough, Epigastric Discomfort, Jaundice
on Apr 15, 2004 Female patient from IRELAND , weighting 145.5 lb, was diagnosed with cardiac failure congestive and was treated with Perindopril (View Usage). Patient experienced the following unwanted or unexpected effects: bile duct stone, cough, epigastric discomfort, jaundice (What is jaundice?). Perindopril dosage: Daily Dose: 4 Milligram(s). Patient was hospitalized.

4814540-4 | Dyspnoea, Shock
on Nov 19, 2004 Male patient from POLAND , weighting 174.2 lb, was diagnosed with cardiac failure congestive and was treated with Perindopril (View Usage). Patient had the following side effects: dyspnoea, shock. Perindopril dosage: Daily Dose: 4 Milligram(s).

4811207-3 | Bladder Disorder, Coma, Head Injury, Subarachnoid Haemorrhage
Patient was taking Perindopril (View Usage). After Perindopril was administered, patient had the following side effects: bladder disorder, coma, head injury, subarachnoid haemorrhage on Oct 28, 2002 from UNITED KINGDOM Additional patient health information: Male patient , weighting 143.3 lb, was diagnosed with cardiac failure congestive and. Perindopril dosage: Daily Dose: 2 Milligram(s). Patient was hospitalized.

4811200-0 | Atrial Fibrillation, Intestinal Obstruction, Ventricular Failure
Adverse event was reported on Jan 14, 2005 by a Male patient taking Perindopril (View Usage) (Dosage: Daily Dose: 4 Milligram(s)) was diagnosed with cardiac failure congestive, ill-defined disorder and. Location: RUSSIAN FEDERATION , weighting 154.3 lb, Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), intestinal obstruction, ventricular failure. During the same period patient was treated with CONCOR (View Concor Review and Concor Label ). Patient was hospitalized.

4810919-5 | Haemoptysis, Myocardial Infarction, Pleural Effusion, Pyrexia, Staphylococcal Infection, Tuberculosis
on Apr 10, 2003 Female patient from UNITED KINGDOM , weighting 163.1 lb, was diagnosed with cardiac failure congestive, ill-defined disorder and was treated with Perindopril (View Usage). Patient had the following side effects: haemoptysis, myocardial infarction, pleural effusion, pyrexia, staphylococcal infection (What is staphylococcal infection?), tuberculosis (What is tuberculosis?). Perindopril dosage: Daily Dose: 4 Milligram(s). During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), DF118 (View Df118 Review and Df118 Label ), OXYBUTYNIN (View Oxybutynin Review and Oxybutynin Label ), FRUSEMIDE (View Frusemide Review and Frusemide Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

4808246-5 | Arrhythmia, Atrial Fibrillation, Cardiac Disorder, Dementia, Right Ventricular Failure
on Jan 14, 2005 Male patient from RUSSIAN FEDERATION , weighting 172.0 lb, was diagnosed with cardiac failure congestive and was treated with Perindopril (View Usage). After Perindopril was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), atrial fibrillation (What is atrial fibrillation?), cardiac disorder, dementia (What is dementia?), right ventricular failure. Perindopril dosage: Daily Dose: 4 Milligram(s). Patient was hospitalized.

4767151-3 | Blood Creatine Increased, Blood Potassium Increased, Blood Urea Increased, C-reactive Protein Increased, Malaise, Nausea, Renal Failure, Urinary Tract Infection
Patient was taking Perindopril (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine increased, blood potassium increased, blood urea increased, c-reactive protein increased, malaise, nausea (What is nausea?), renal failure, urinary tract infection (What is urinary tract infection?) on Sep 05, 2005 from UNITED KINGDOM Additional patient health information: Female patient , 82 years of age, . Perindopril dosage: 4 Mg, Qd. During the same period patient was treated with WARFARIN (View Warfarin Review and Warfarin Label ), ALBUTEROL SULFATE HFA (5 Mg, Qid) (View Albuterol Sulfate Hfa Review and Albuterol Sulfate Hfa Label ), PANTOPRAZOLE (40 Mg, Qd) (View Pantoprazole Review and Pantoprazole Label ), PREDNISOLONE (5 Mg, Qd) (View Prednisolone Review and Prednisolone Label ), DOXAZOSIN (4 Mg, Bid) (View Doxazosin Review and Doxazosin Label ), AMLODIPINE (5 Mg, Qd) (View Amlodipine Review and Amlodipine Label ), BENDROFLUAZIDE (2.5 Mg, Qd) (View Bendrofluazide Review and Bendrofluazide Label ), CALCICHEW D3 (1 Ot, Bid) (View Calcichew D3 Review and Calcichew D3 Label ). Patient was hospitalized.

4749429-2 | Hypereosinophilic Syndrome, Liver Function Test Abnormal
Adverse event was reported on Aug 10, 2005 by a Male patient taking Perindopril (View Usage) (Dosage: Daily Dose: 4 Milligram(s)) was diagnosed with hypertension, ill-defined disorder and. Location: FINLAND , 57 years of age, Patient had the following side effects: hypereosinophilic syndrome, liver function test abnormal. During the same period patient was treated with AMLODIPINE (Daily Dose: 5 Milligram(s)) (View Amlodipine Review and Amlodipine Label ). Patient was hospitalized.

4738084-3 | Blood Sodium Decreased, Eosinophil Count Increased, Hypotension, Laboratory Test Abnormal, Lymphadenopathy Mediastinal, Malaise, Nausea, Pulmonary Eosinophilia, Pyrexia
on Jul 25, 2005 Female patient from UNITED KINGDOM , 68 years of age, was diagnosed with hypertension and was treated with Perindopril (View Usage). After Perindopril was administered, patient had the following side effects: blood sodium decreased, eosinophil count increased, hypotension, laboratory test abnormal, lymphadenopathy mediastinal, malaise, nausea (What is nausea?), pulmonary eosinophilia, pyrexia. Perindopril dosage: Dose: Unk. During the same period patient was treated with FUROSEMIDE AMILORIDE (Dose: Unk) (View Furosemide Amiloride Review and Furosemide Amiloride Label ), FLUTICASONE PROPIONATE (Dose: Unk) (View Fluticasone Propionate Review and Fluticasone Propionate Label ), ALBUTEROL SULFATE HFA (Dose: Unk) (View Albuterol Sulfate Hfa Review and Albuterol Sulfate Hfa Label ). Patient was hospitalized.

4701920-0 | Hepatocellular Damage, Muscle Injury, Renal Disorder
on Jun 21, 2005 Female patient from , 84 years of age, was diagnosed with gout (What is gout?), blood cholesterol increased, coronary artery disease (What is coronary artery disease?) and was treated with Perindopril (View Usage). Patient experienced the following unwanted or unexpected effects: hepatocellular damage, muscle injury, renal disorder. Perindopril dosage: . During the same period patient was treated with ZOCOR (View Zocor Review and Zocor Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), PRAZOSIN (View Prazosin Review and Prazosin Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.